Anyone involved in this trial? It's in Michigan, could be a useful option for me.
ARX517: Anyone involved in this trial... - Fight Prostate Ca...
ARX517
hi, one of the guys on here was, try to search for arx517, I will try as well…very promising drug
PapaDugi!!!
Here is my old post, check the comments: healthunlocked.com/advanced...
Thank you, exactly the data I have been looking for. Now, I'm not the smartest kid in the class so: ARX517 seems a lot like Pluvicto?
ARX517 and Pluvicto target PSMA on prostate cancer cells but work differently. ARX517 is an antibody-drug conjugate that delivers a cytotoxic agent directly to cancer cells. Pluvicto, a radioligand therapy, uses a radioactive molecule attached to a PSMA-targeting ligand, delivering radiation to kill cancer cells. ARX517's mechanism is chemical, through the drug it carries, while Pluvicto's is radiological, utilizing targeted radiation.
ah check also AMG 509 and janx007 molecules and the related trials
Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer